Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Aripiprazole in Long-Term Maintenance for Irritability in Autism Disorder
2017-000174-11Phase 4
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aripiprazole in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
aripiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on 2017-000174-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000174-11.